Revelation Biosciences In...

0.02
0.01 (33.33%)
At close: Feb 11, 2025, 2:54 PM
0.02
0.00%
After-hours Feb 11, 2025, 07:50 PM EST
undefined%
Bid 0.01
Market Cap 2.10M
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -4.773
PE Ratio (ttm) n/a
Forward PE n/a
Analyst n/a
Ask 0.02
Volume 6,305
Avg. Volume (20D) 90,992.658
Open 0.01
Previous Close 0.01
Day's Range 0.01 - 0.02
52-Week Range 0.01 - 0.02
Beta undefined

About REVBW

Revelation Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of immunologic-based therapeutics and diagnostics for the prevention and treatment of disease. The company's lead therapeutic candidate is REVTx-99, an intranasal immunomodulator to prevent or treat infections caused by various respiratory viruses, such as SARS-CoV-2 comprising its variants, influenza A and B, parainfluenza, rhinovirus, and RSV, a...

Industry Biotechnology
Sector Healthcare
IPO Date n/a
Employees 9
Stock Exchange NASDAQ
Ticker Symbol REVBW
No News article available yet